These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

777 related items for PubMed ID: 25755774

  • 1. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
    Wang CY, Hua L, Yao KH, Chen JT, Zhang JJ, Hu JH.
    Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
    Chen X, Liu L, Zhu W.
    Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
    [Abstract] [Full Text] [Related]

  • 3. Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer.
    Zhou B, Jing XY, Wu JQ, Xi HF, Lu GJ.
    Int J Clin Exp Pathol; 2014; 7(12):8893-8. PubMed ID: 25674261
    [Abstract] [Full Text] [Related]

  • 4. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion.
    Wu SW, Hao YP, Qiu JH, Zhang DB, Yu CG, Li WH.
    Minerva Med; 2017 Aug; 108(4):317-323. PubMed ID: 28248065
    [Abstract] [Full Text] [Related]

  • 5. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Zheng J, Zhao S, He X, Zheng Z, Bai W, Duan Y, Cheng S, Wang J, Liu X, Zhang G.
    Biochem Biophys Res Commun; 2016 Nov 25; 480(4):508-514. PubMed ID: 27558961
    [Abstract] [Full Text] [Related]

  • 6. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
    Huang S, Qing C, Huang Z, Zhu Y.
    Diagn Pathol; 2016 Jun 10; 11(1):49. PubMed ID: 27283598
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer.
    Zhang XF, Liu T, Li Y, Li S.
    Int J Clin Exp Pathol; 2015 Jun 10; 8(8):9440-5. PubMed ID: 26464701
    [Abstract] [Full Text] [Related]

  • 8. Low expression of long non-coding RNA LET inhibits carcinogenesis of cervical cancer.
    Jiang S, Wang HL, Yang J.
    Int J Clin Exp Pathol; 2015 Jun 10; 8(1):806-11. PubMed ID: 25755778
    [Abstract] [Full Text] [Related]

  • 9. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM, Teng F.
    Int J Clin Exp Pathol; 2015 Jun 10; 8(4):4008-14. PubMed ID: 26097588
    [Abstract] [Full Text] [Related]

  • 10. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.
    Xie X, Liu HT, Mei J, Ding FB, Xiao HB, Hu FQ, Hu R, Wang MS.
    Int J Clin Exp Pathol; 2014 Jun 10; 7(12):8881-6. PubMed ID: 25674259
    [Abstract] [Full Text] [Related]

  • 11. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
    Tian ZZ, Guo XJ, Zhao YM, Fang Y.
    Int J Clin Exp Pathol; 2015 Jun 10; 8(11):15138-42. PubMed ID: 26823857
    [Abstract] [Full Text] [Related]

  • 12. Increased expression of LncRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer.
    Li L, Zhang L, Zhang Y, Zhou F.
    Biomed Pharmacother; 2015 May 10; 72():109-12. PubMed ID: 26054683
    [Abstract] [Full Text] [Related]

  • 13. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Yanaka Y, Kobayashi K, Higuchi K, Kojima K, Kawano T.
    J Clin Pathol; 2015 Oct 10; 68(10):795-801. PubMed ID: 26043748
    [Abstract] [Full Text] [Related]

  • 14. Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer.
    Song W, Liu YY, Peng JJ, Liang HH, Chen HY, Chen JH, He WL, Xu JB, Cai SR, He YL.
    J Gastroenterol; 2016 Feb 10; 51(2):119-29. PubMed ID: 26045391
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS, Wang YF, Zhang XQ, Lv JM, Li Y, Liu XX, Xu TP.
    Neoplasma; 2016 Feb 10; 63(2):223-30. PubMed ID: 26774144
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.